Eliquis (apixaban) Disease Interactions
There are 3 disease interactions with Eliquis (apixaban):
Factor Xa inhibitors (Includes Eliquis) ↔ bleeding
Severe Potential Hazard, Moderate plausibility. Applies to: Bleeding
The use of factor Xa inhibitors is contraindicated in patients with active pathological bleeding. Its use increases the risk of bleeding and can cause serious or fatal bleeding. Caution is recommended when prescribing these agents to patients at increased risk of bleeding. When using these agents, the risk of thrombotic events should be weighed against the risk of bleeding.
Factor Xa inhibitors (Includes Eliquis) ↔ hepatic impairment
Severe Potential Hazard, Moderate plausibility. Applies to: Liver Disease
In general, the manufacturer recommends avoiding the use of factor Xa inhibitors in patients with moderate and severe hepatic impairment or with any hepatic disease associated with coagulopathy as drug exposure and bleeding risk may be increased.
Factor Xa inhibitors (Includes Eliquis) ↔ valvular heart disease
Severe Potential Hazard, Moderate plausibility. Applies to: Prosthetic Heart Valves
The use of factor Xa inhibitors is not recommended in patients with prosthetic heart valves as no studies have been conducted for safety and efficacy.
Eliquis (apixaban) drug interactions
There are 408 drug interactions with Eliquis (apixaban)
More about Eliquis (apixaban)
- Eliquis Side Effects
- During Pregnancy
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 75 Reviews
- Drug class: factor Xa inhibitors
- FDA Alerts (1)
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.